Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's disease
Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's disease
About this item
Full title
Author / Creator
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
Behçet's disease (BD) is a recurrent multisystem inflammatory disease. Anti-tumor necrosis factor (TNF) α agents have been used to treat patients with intestinal BD with severe disease activity or those who are resistant to conventional treatments; however, the long-term efficacy of anti-TNFα agents in intestinal BD remains unclear. In the present...
Alternative Titles
Full title
Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_920163628dcd4c5d8df150f897c4b2a7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_920163628dcd4c5d8df150f897c4b2a7
Other Identifiers
ISSN
1471-230X
E-ISSN
1471-230X
DOI
10.1186/s12876-022-02221-0
